Keywords: genentech, dnase, effective, cf, results, phase, ii

GENENTECH'S DNase EFFECTIVE IN CF

Article | 11 May 1992

Print This

Results of a US Phase II study have demonstrated that Genentech's DNase is an effective treatment for the chronic lung ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in